Evidence map›Paper›PMID 32117117›Full record

ArticleFrontiers in microbiology2020

Molecular Basis of Growth Inhibition by Acetate of an Adenylate Cyclase-Deficient Mutant of

Natalie Wolf, Michael Bussmann, Abigail Koch-Koerfges, Nino Katcharava, Julia Schulte, Tino Polen, Johannes Hartl, Julia A Vorholt, Meike Baumgart, Michael Bott

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. High-quality physiology ofFrontiers in bioengineering and biotechnology · 2023
    Article
  2. Article
  3. TheMicroorganisms · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Natalie WolfIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Michael BussmannIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Abigail Koch-KoerfgesIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Nino KatcharavaIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Julia SchulteIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Tino PolenIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Johannes HartlInstitute of Microbiology, ETH Zürich, Zurich, Switzerland.
Julia A VorholtInstitute of Microbiology, ETH Zürich, Zurich, Switzerland.
Meike BaumgartIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Michael BottIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich, Jülich, Germany.
Forschungszentrum Jülich · DEETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In

Indexed as

acetateadenylate cyclasecAMPCorynebacterium glutamicumcytochrome bc1-aa3 supercomplexGlxRmembrane potentialuncouplers

Identifiers

PMID32117117
PMCPMC7026483
OpenAlexW3005747234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.